Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
Top Cited Papers
- 6 February 2006
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (3), 228-234
- https://doi.org/10.1016/s1474-4422(06)70355-6
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?Journal of Neurology, Neurosurgery & Psychiatry, 2005
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- Back to the future: the 'old-fashioned' way to new medications for neurodegenerationNature Medicine, 2004
- Value of CSF β-amyloid1–42 and tau as predictors of Alzheimer's disease in patients with mild cognitive impairmentMolecular Psychiatry, 2003
- Looking Backward to Move Forward: Early Detection of Neurodegenerative DisordersScience, 2003
- Patterns of Brain Activation in People at Risk for Alzheimer's DiseaseNew England Journal of Medicine, 2000
- Development of Cognitive Instruments for Use in Clinical Trials of Antidementia DrugsAlzheimer Disease & Associated Disorders, 1997
- The Ten Point Clock Test: A Quick Screen and Grading Method for Cognitive Impairment in Medical and Surgical PatientsThe International Journal of Psychiatry in Medicine, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984